2019
DOI: 10.1136/annrheumdis-2018-214677
|View full text |Cite
|
Sign up to set email alerts
|

Altered cognitive function in systemic lupus erythematosus and associations with inflammation and functional and structural brain changes

Abstract: ObjectivesCognitive dysfunction (CD) is common in systemic lupus erythematosus (SLE) but the cause remains unclear and treatment options are limited. We aimed to compare cognitive function in SLE and healthy controls (HCs) using both behavioural and neuroimaging techniques.MethodsPatients with SLE with stable disease and HCs were recruited. Clinical and psychological data were collected along with a blood sample for relevant biomarkers. Neurocognitive function was assessed using tests from the Cambridge Neurop… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
44
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 58 publications
(45 citation statements)
references
References 41 publications
1
44
0
Order By: Relevance
“…In fact, there is evidence for the involvement of multiple aspects of the immune system in NPSLE, including neurotoxic autoantibodies, pro-inflammatory cytokines and cell-mediated effects, in conjunction with abnormalities in neuroimmune interfaces including the choroid plexus and blood-brain barrier which allow systemic autoimmune drivers into the central nervous system [21,24]. Specifically, several studies have pointed to increased systemic levels of cytokines such as interleukin 6 (IL-6) and neurotoxic anti-N-methyl-D-aspartate receptor (NMDAR) antibodies in SLE patients with CD [25][26][27]. In addition, type I interferon (IFN-I) and anti-NMDAR antibodies were shown to enhance microglia activation, leading to aberrant synaptic pruning with subsequent CD [28,29].…”
Section: Pathogenesismentioning
confidence: 99%
“…In fact, there is evidence for the involvement of multiple aspects of the immune system in NPSLE, including neurotoxic autoantibodies, pro-inflammatory cytokines and cell-mediated effects, in conjunction with abnormalities in neuroimmune interfaces including the choroid plexus and blood-brain barrier which allow systemic autoimmune drivers into the central nervous system [21,24]. Specifically, several studies have pointed to increased systemic levels of cytokines such as interleukin 6 (IL-6) and neurotoxic anti-N-methyl-D-aspartate receptor (NMDAR) antibodies in SLE patients with CD [25][26][27]. In addition, type I interferon (IFN-I) and anti-NMDAR antibodies were shown to enhance microglia activation, leading to aberrant synaptic pruning with subsequent CD [28,29].…”
Section: Pathogenesismentioning
confidence: 99%
“…The cognitive function assessment form has been developed to define a series of standardized detection tools that can be used to determine the integrity of central nervous system function. 14 In recent decades, a large number of studies have been conducted on cognitive impairment in SLE using various cognitive scales, but the reported incidence rate of SLE-related cognitive impairment varies widely. 15 MMSE is a 30-point questionnaire that is used extensively in clinical research.…”
Section: Discussionmentioning
confidence: 99%
“…14 An innovative approach was put forward by Barraclough and colleagues, who combined a functional magnetic resonance (fMRI) approach with tests from the computerized Cambridge Neuropsychological Test Automated Battery (CANTAB) to examine brain responses to working memory tasks in patients with systemic lupus erythematosus. 15 The study identified a dissociated profile, with deficits in sustained attention, and compensatory brain activity to maintain similar levels of working memory performance when compared to healthy controls. An advantage of such computerized neuropsychological batteries is that they represent sensitive, standardized tools which offer both speed and accuracy indexes of performance.…”
Section: Introductionmentioning
confidence: 98%
“…Our target was a sample of patients with RA, tested with more sensitive measures from two computerized neuropsychological batteries, CANTAB 17 and Automated Working Memory Assessment (AWMA). 18 CANTAB tasks have shown sensitivity to cognitive dysfunction and have been widely used across different clinical groups, 15,[19][20][21] yet to our knowledge, they have not been administered to patients with RA. We aimed to provide a detailed computerized investigation of verbal and visuospatial short-term and working memory (dys)functions in RA patients, assessing both accuracy and response speed, while controlling for variables known to influence cognitive function in this condition (age, disease-related activity, affective problems, other clinical parameters).…”
Section: Introductionmentioning
confidence: 99%